These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 33893730)

  • 21. Machine-learning repurposing of DrugBank compounds for opioid use disorder.
    Feng H; Jiang J; Wei GW
    Comput Biol Med; 2023 Jun; 160():106921. PubMed ID: 37178605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug Repurposing Approaches: Existing Leads For Novel Threats And Drug Targets.
    Usha T; Middha SK; Kukanur AA; Shravani RV; Anupama MN; Harshitha N; Rahamath A; Kukanuri SA; Goyal AK
    Curr Protein Pept Sci; 2020 Sep; ():. PubMed ID: 32957901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repurposing therapeutics for COVID-19: Rapid prediction of commercially available drugs through machine learning and docking.
    Mohapatra S; Nath P; Chatterjee M; Das N; Kalita D; Roy P; Satapathi S
    PLoS One; 2020; 15(11):e0241543. PubMed ID: 33180803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An Application of Computational Drug Repurposing Based on Transcriptomic Signatures.
    Karatzas E; Kolios G; Spyrou GM
    Methods Mol Biol; 2019; 1903():149-177. PubMed ID: 30547441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prioritization of candidate cancer drugs based on a drug functional similarity network constructed by integrating pathway activities and drug activities.
    Di J; Zheng B; Kong Q; Jiang Y; Liu S; Yang Y; Han X; Sheng Y; Zhang Y; Cheng L; Han J
    Mol Oncol; 2019 Oct; 13(10):2259-2277. PubMed ID: 31408580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting non-structural proteins of Hepatitis C virus for predicting repurposed drugs using QSAR and machine learning approaches.
    Kamboj S; Rajput A; Rastogi A; Thakur A; Kumar M
    Comput Struct Biotechnol J; 2022; 20():3422-3438. PubMed ID: 35832613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug Repurposing Using Modularity Clustering in Drug-Drug Similarity Networks Based on Drug-Gene Interactions.
    Groza V; Udrescu M; Bozdog A; Udrescu L
    Pharmaceutics; 2021 Dec; 13(12):. PubMed ID: 34959398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Machine Learning Applications in Drug Repurposing.
    Yang F; Zhang Q; Ji X; Zhang Y; Li W; Peng S; Xue F
    Interdiscip Sci; 2022 Mar; 14(1):15-21. PubMed ID: 35066811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Network-based stage-specific drug repurposing for Alzheimer's disease.
    Savva K; Zachariou M; Bourdakou MM; Dietis N; Spyrou GM
    Comput Struct Biotechnol J; 2022; 20():1427-1438. PubMed ID: 35386099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Computer-aided drug repurposing for cancer therapy: Approaches and opportunities to challenge anticancer targets.
    Mottini C; Napolitano F; Li Z; Gao X; Cardone L
    Semin Cancer Biol; 2021 Jan; 68():59-74. PubMed ID: 31562957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deep Learning-Assisted Repurposing of Plant Compounds for Treating Vascular Calcification: An In Silico Study with Experimental Validation.
    Chao CT; Tsai YT; Lee WT; Yeh HY; Chiang CK
    Oxid Med Cell Longev; 2022; 2022():4378413. PubMed ID: 35035662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integration of genetic variants and gene network for drug repurposing in colorectal cancer.
    Irham LM; Wong HS; Chou WH; Adikusuma W; Mugiyanto E; Huang WC; Chang WC
    Pharmacol Res; 2020 Nov; 161():105203. PubMed ID: 32950641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Network-based drug repurposing for HPV-associated cervical cancer.
    Ahmed F; Yang YJ; Samantasinghar A; Kim YW; Ko JB; Choi KH
    Comput Struct Biotechnol J; 2023; 21():5186-5200. PubMed ID: 37920815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EGeRepDR: An enhanced genetic-based representation learning for drug repurposing using multiple biomedical sources.
    Muniyappan S; Rayan AXA; Varrieth GT
    J Biomed Inform; 2023 Nov; 147():104528. PubMed ID: 37858852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthetic repurposing of drugs against hypertension: a datamining method based on association rules and a novel discrete algorithm.
    Masoudi-Sobhanzadeh Y; Masoudi-Nejad A
    BMC Bioinformatics; 2020 Jul; 21(1):313. PubMed ID: 32677879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nortriptyline hydrochloride, a potential candidate for drug repurposing, inhibits gastric cancer by inducing oxidative stress by triggering the Keap1-Nrf2 pathway.
    Zhu C; Lu Y; Wang S; Song J; Ding Y; Wang Y; Dong C; Liu J; Qiu W; Qi W
    Sci Rep; 2024 Mar; 14(1):6050. PubMed ID: 38480798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-Mediated Drug Repurposing Unveiled Potential Candidate Drugs for Prolactinoma Treatment.
    Aydin B; Arslan S; Bayraklı F; Karademir B; Arga KY
    Neuroendocrinology; 2022; 112(2):161-173. PubMed ID: 33706313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A human-based multi-gene signature enables quantitative drug repurposing for metabolic disease.
    Timmons JA; Anighoro A; Brogan RJ; Stahl J; Wahlestedt C; Farquhar DG; Taylor-King J; Volmar CH; Kraus WE; Phillips SM
    Elife; 2022 Jan; 11():. PubMed ID: 35037854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An Integrative Heterogeneous Graph Neural Network-Based Method for Multi-Labeled Drug Repurposing.
    Sadeghi S; Lu J; Ngom A
    Front Pharmacol; 2022; 13():908549. PubMed ID: 35873597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Developing Novel Drug Candidates and Repurposed Drugs for Prostate Cancer Based on Molecular Profiles.
    Mokou M; Frantzi M; Mischak H; Vlahou A; Latosinska A
    Curr Med Chem; 2021; 28(40):8392-8415. PubMed ID: 34036903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.